| Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience T de Castro, LS Jochheim, M Bathon, S Welland, B Scheiner, K Shmanko, ... Therapeutic Advances in Medical Oncology 14, 17588359221080298, 2022 | 68 | 2022 |
| Comparison of intranasal outer membrane vesicles with cholera toxin and injected MF59C. 1 as adjuvants for malaria transmission blocking antigens AnAPN1 and Pfs48/45 M Pritsch, N Ben-Khaled, M Chaloupka, S Kobold, N Berens-Riha, ... Journal of immunology research 2016 (1), 3576028, 2016 | 62 | 2016 |
| Artificial intelligence in chest radiography reporting accuracy: added clinical value in the emergency unit setting without 24/7 radiology coverage J Rudolph, C Huemmer, FC Ghesu, A Mansoor, A Preuhs, A Fieselmann, ... Investigative radiology 57 (2), 90-98, 2022 | 34 | 2022 |
| Atezolizumab and bevacizumab with transarterial chemoembolization in hepatocellular carcinoma: the DEMAND trial protocol NB Khaled, M Seidensticker, J Ricke, J Mayerle, B Oehrle, D Rössler, ... Future Oncology 18 (12), 1423-1435, 2022 | 30 | 2022 |
| Molecular mechanisms of ischaemia-reperfusion injury and regeneration in the liver-shock and surgery-associated changes E Pretzsch, H Nieß, NB Khaled, F Bösch, M Guba, J Werner, M Angele, ... International journal of molecular sciences 23 (21), 12942, 2022 | 27 | 2022 |
| Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study D Roessler, O Öcal, AB Philipp, D Markwardt, S Munker, J Mayerle, ... Journal of Cancer Research and Clinical Oncology 149 (7), 3065-3073, 2023 | 25 | 2023 |
| Baseline Interleukin-6 and-8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc … O Öcal, K Schütte, J Kupčinskas, E Morkunas, G Jurkeviciute, EN de Toni, ... Journal of cancer research and clinical oncology, 1-11, 2022 | 24 | 2022 |
| Extending the use of atezolizumab and bevacizumab to a liver transplant recipient: need for a posttransplant registry NB Khaled, D Roessler, FP Reiter, M Seidensticker, M Guba, EN De Toni Liver Transplantation 27 (6), 928-929, 2021 | 18 | 2021 |
| An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets J Griger, SA Widholz, M Jesinghaus, N de Andrade Krätzig, S Lange, ... Cancer cell 41 (7), 1327-1344. e10, 2023 | 16 | 2023 |
| Atezolizumab plus bevacizumab in patients with advanced and progressing hepatocellular carcinoma: retrospective multicenter experience F Sinner, M Pinter, B Scheiner, TJ Ettrich, N Sturm, ... Cancers 14 (23), 5966, 2022 | 16 | 2022 |
| Patterns of pseudoprogression across different cancer entities treated with immune checkpoint inhibitors S Mönch, MM Heimer, M Winkelmann, A Guertler, M Schlaak, A Tufman, ... Cancer Imaging 23 (1), 58, 2023 | 13 | 2023 |
| Advances in pharmacotherapy of hepatocellular carcinoma: a state-of-the-art review FP Reiter, N Ben Khaled, L Ye, C Zhang, M Seidensticker, ... Digestive Diseases 40 (5), 565-580, 2022 | 13 | 2022 |
| Combined hepatocellular-cholangiocarcinoma: biology, diagnosis, and management L Ye, JS Schneider, N Ben Khaled, P Schirmacher, C Seifert, L Frey, Y He, ... Liver Cancer 13 (1), 6-28, 2024 | 12 | 2024 |
| IL12/23 blockade for refractory immune-mediated colitis: 2-center experience AS Thomas, SE Lee, M Shatila, EN De Toni, HP Török, NB Khaled, ... Official journal of the American College of Gastroenterology| ACG 118 (9 …, 2023 | 12 | 2023 |
| Clinically focused multi-cohort benchmarking as a tool for external validation of artificial intelligence algorithm performance in basic chest radiography analysis J Rudolph, B Schachtner, N Fink, V Koliogiannis, V Schwarze, S Goller, ... Scientific Reports 12 (1), 12764, 2022 | 11 | 2022 |
| Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial M Seidensticker, O Öcal, K Schütte, P Malfertheiner, T Berg, C Loewe, ... JHEP Reports 5 (5), 100699, 2023 | 10 | 2023 |
| Current state of multidisciplinary treatment in cholangiocarcinoma N Ben Khaled, S Jacob, D Rössler, F Bösch, EN De Toni, J Werner, ... Digestive Diseases 40 (5), 581-595, 2022 | 10 | 2022 |
| p70 ribosomal protein S6 kinase is a checkpoint of human hepatic stellate cell activation and liver fibrosis in mice FP Reiter, L Ye, A Ofner, TS Schiergens, A Ziesch, L Brandl, NB Khaled, ... Cellular and Molecular Gastroenterology and Hepatology 13 (1), 95-112, 2022 | 10 | 2022 |
| Peripheral priming induces plastic transcriptomic and proteomic responses in circulating neutrophils required for pathogen containment R Kaiser, C Gold, M Joppich, Q Loew, A Akhalkatsi, TT Mueller, ... Science Advances 10 (12), eadl1710, 2024 | 7 | 2024 |
| Image-guided local treatment for unresectable intrahepatic cholangiocarcinoma—role of interventional radiology MP Fabritius, N Ben Khaled, WG Kunz, J Ricke, M Seidensticker Journal of Clinical Medicine 10 (23), 5574, 2021 | 7 | 2021 |
